0001661763-16-000002.txt : 20160518
0001661763-16-000002.hdr.sgml : 20160518
20160518161041
ACCESSION NUMBER: 0001661763-16-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160518
DATE AS OF CHANGE: 20160518
EFFECTIVENESS DATE: 20160518
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ascendance Biotechnology, Inc.
CENTRAL INDEX KEY: 0001661763
IRS NUMBER: 474863132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-263446
FILM NUMBER: 161660588
BUSINESS ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 1500
CITY: MEDFORD
STATE: MA
ZIP: 02155
BUSINESS PHONE: 781 391 0205
MAIL ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 1500
CITY: MEDFORD
STATE: MA
ZIP: 02155
D
1
primary_doc.xml
X0707
D
LIVE
0001661763
Ascendance Biotechnology, Inc.
200 BOSTON AVENUE
SUITE 1500
MEDFORD
MA
MASSACHUSETTS
02155
781 391 0205
DELAWARE
None
None
Corporation
true
2015
Jeffrey
D.
Janus
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Executive Officer
Director
Promoter
Vincent
R., Jr.
Zurawski
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Executive Officer
Director
Promoter
John
K.
McGeehan
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Executive Officer
Promoter
Martin
J.
Joyce
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Executive Officer
Alfred
D.
Kingsley
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Director
Morton
Collins
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Director
Robert
G.
Wilkens
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Director
Michael
D.
West
c/o Ascendance Biotechnology, Inc.
200 Boston Avenue, Suite 1500
Medford
MA
MASSACHUSETTS
02155
Director
Biotechnology
Decline to Disclose
- 06b
false
2016-05-05
false
true
false
0
300000
230000
70000
false
10
0
0
0
false
Ascendance Biotechnology, Inc.
/s/ Vincent R. Zurawski, Jr.
Vincent R. Zurawski, Jr.
Chief Executive Officer
2016-05-17